General Information About Zellweger Syndrome
Disease Details and Frequently Asked Questions
It is a fatal, inherited metabolic disorder belonging to the peroxisome biogenesis disorders (PBD) spectrum. Due to specific genetic errors, microscopic cellular structures called 'peroxisomes'—which function as the cell's waste disposal and lipid metabolism centers—fail to form entirely. Consequently, the infant's body rapidly becomes intoxicated by its own accumulated toxic metabolic byproducts.
The disorder follows an autosomal recessive inheritance pattern. This means that if both the mother and the father are asymptomatic carriers of the defective PEX gene, there is a 25% statistical probability with each pregnancy that the infant will be born with this syndrome.
Immediately following birth, affected neonates present with profound systemic muscle flaccidity (severe hypotonia, often described as a 'rag doll' appearance), failure to thrive due to an absent sucking reflex, distinctive craniofacial dysmorphism (high forehead, flattened nasal bridge), and significant visual and sensorineural hearing impairments.
Because cellular toxic waste and very long-chain fatty acids cannot be degraded, they accumulate pathologically. This accumulation leads to massive hepatomegaly (liver enlargement), neonatal jaundice, and rapid progression to cirrhosis. Concurrently, within the central nervous system, normal myelination (the formation of protective nerve sheaths) is severely disrupted, triggering intractable epileptic seizures and profound global developmental delay.
The diagnostic cornerstone involves specialized biochemical blood assays demonstrating extraordinarily elevated levels of Very Long-Chain Fatty Acids (VLCFA). Definitive molecular confirmation is achieved through advanced genetic testing, pinpointing the specific pathogenic mutations within the PEX gene family.
Currently, there is no genetic cure or specific disease-modifying therapy for this syndrome, and the clinical prognosis is extremely poor. The vast majority of affected infants succumb within the first year of life, primarily due to respiratory compromise or fulminant hepatic failure. Medical management is strictly supportive and palliative, focusing exclusively on maximizing patient comfort (e.g., administering anti-epileptic medications for seizure control and utilizing gastric feeding tubes for nutritional support).
Our health library contents are prepared for informational purposes only and with scientific data available at the time of recording. For all your questions, concerns, diagnosis, or treatment regarding your health, please consult your doctor or a healthcare institution.
